{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:59:20Z","timestamp":1784354360045,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jaad.2016.01.054","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T23:02:52Z","timestamp":1463180572000},"page":"1248-1251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients"],"prefix":"10.1016","volume":"74","author":[{"given":"Feriel","family":"Fennira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Cordel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Franc\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.01.054_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2133.2011.10693.x","article-title":"Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome","volume":"166","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.01.054_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaad.2011.01.015","article-title":"Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare","volume":"66","author":"Braunstein","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.01.054_bib3","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/ar4111","article-title":"Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus","volume":"14","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaad.2016.01.054_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2013.11.007","article-title":"Lenalidomide in treatment-refractory cutaneous lupus erythematosus: efficacy and safety in a 52-week trial","volume":"70","author":"Okon","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.01.054_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archdermatol.2009.30","article-title":"Lenalidomide for the treatment of resistant discoid lupus erythematosus","volume":"145","author":"Shah","year":"2009","journal-title":"Arch Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216013323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216013323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:40:42Z","timestamp":1759272042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216013323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0190962216013323"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.01.054","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.01.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, Occupational Safety and Health Research Institute. Published by Elsevier. All rights reserved.","name":"copyright","label":"Copyright"}]}}